Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia.
Jordan SC, Zakowski P, Tran HP, Smith EA, Gaultier C, Marks G, Zabner R, Lowenstein H, Oft J, Bluen B, Le C, Shane R, Ammerman N, Vo A, Chen P, Kumar S, Toyoda M, Ge S, Huang E. Jordan SC, et al. Among authors: ammerman n. Clin Infect Dis. 2020 Dec 15;71(12):3168-3173. doi: 10.1093/cid/ciaa812. Clin Infect Dis. 2020. PMID: 32575124 Free PMC article.
A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients.
Jordan SC, Choi J, Aubert O, Haas M, Loupy A, Huang E, Peng A, Kim I, Louie S, Ammerman N, Najjar R, Puliyanda D, Vo A. Jordan SC, et al. Among authors: ammerman n. Am J Transplant. 2018 Dec;18(12):2955-2964. doi: 10.1111/ajt.14767. Epub 2018 May 14. Am J Transplant. 2018. PMID: 29637714 Free article. Clinical Trial.
Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients.
Huang E, Vo A, Choi J, Ammerman N, Lim K, Sethi S, Kim I, Kumar S, Najjar R, Peng A, Jordan SC. Huang E, et al. Among authors: ammerman n. Clin J Am Soc Nephrol. 2020 Jan 7;15(1):109-116. doi: 10.2215/CJN.04840419. Epub 2019 Dec 16. Clin J Am Soc Nephrol. 2020. PMID: 31843975 Free PMC article. Clinical Trial.
Interleukin-6: An Important Mediator of Allograft Injury.
Jordan SC, Ammerman N, Choi J, Kumar S, Huang E, Toyoda M, Kim I, Wu G, Vo A. Jordan SC, et al. Among authors: ammerman n. Transplantation. 2020 Dec;104(12):2497-2506. doi: 10.1097/TP.0000000000003249. Transplantation. 2020. PMID: 32235253 Review.
Successful Treatment of Severe COVID-19 Pneumonia With Clazakizumab in a Heart Transplant Recipient: A Case Report.
Vaidya G, Czer LSC, Kobashigawa J, Kittleson M, Patel J, Chang D, Kransdorf E, Shikhare A, Tran H, Vo A, Ammerman N, Huang E, Zabner R, Jordan S. Vaidya G, et al. Among authors: ammerman n. Transplant Proc. 2020 Nov;52(9):2711-2714. doi: 10.1016/j.transproceed.2020.06.003. Epub 2020 Jun 7. Transplant Proc. 2020. PMID: 32563584 Free PMC article.
Donor-derived Cell-free DNA Combined With Histology Improves Prediction of Estimated Glomerular Filtration Rate Over Time in Kidney Transplant Recipients Compared With Histology Alone.
Huang E, Gillespie M, Ammerman N, Vo A, Lim K, Peng A, Najjar R, Sethi S, Jordan SC, Mirocha J, Haas M. Huang E, et al. Among authors: ammerman n. Transplant Direct. 2020 Jul 15;6(8):e580. doi: 10.1097/TXD.0000000000001027. eCollection 2020 Aug. Transplant Direct. 2020. PMID: 33134504 Free PMC article.
76 results